Skip to main content

Table 1 Summary of patient details

From: The accuracy of diagnostic coding for acute kidney injury in England – a single centre study

 

2005

2010

 

N (%)

95% CI

N (%)

95% CI

Number of records examined

58 (100%)

 

63 (100%)

 

Died during admission

30 (50%)

37-63%

29 (46%)

33-59%

Male gender

21 (36%)

23-49%

15 (24%)

13-35%

Diabetic

25 (43%)

30-56%

21 (33%)

21-45%

Hypertensive

18 (31%)

19-43%

19 (30%)

19-42%

Previous IHD or CVD

11 (19%)

9-29%

8 (13%)

4-21%

Heart failure

13 (22%)

11-33%

14 (22%)

12-33%

Recent diarrhoea/vomiting

11 (19%)

9-29%

9 (14%)

5-23%

Admitted to ITU

10 (17%)

7-27%

9 (14%)

5-23%

Haemodialysis/haemofiltration

29 (50%)

37-63%

29 (46%)

33-59%

Pre-admission drug treatment

 

ACE Inhibitor

19 (35%)

22-48%

14 (23%)

12-34%

ARB

5 (9%)

1-17%

9 (15%)

6-24%

Loop diuretic

29 (55%)

37-63%

18 (29%)

17-40%

Thiazide diuretic

5(9%)

1-16%

3 (5%)

0-10%

NSAID

6 (11%)

2-19%

3 (5%)

0-11%

Spironolactone

8 (15%)

5-24%

6 (10%)

2-18%

 

Median (IQR)

Median (IQR)

Age (years)

79 (70–85)

83 (73–88)

Biochemical variables

 

Baseline eGFR (ml/min/1.73m 2 )

49 (29–62)

45 (33–65)

Baseline creatinine (μmol/L)

120 (90–170)

120 (90–155)

Admission creatinine (μmol/L)

265 (178–405)

252 (191–435)

Admission potassium (mmol/L)

5.0 (4.3-6.0)

4.5 (4.1-5.9)

Admission bicarbonate (mmol/L)

17.2 (12.9-21.1)

21.5 (16.8-26.1)

Admission systolic BP (mmHg)

122 (105–143)

127 (111–145)

  1. Count data are expressed as % (N), with 95% CI. Continuous data are expressed as median (IQR). IHD ischaemic heart disease; CVD cerebrovascular disease; ITU Intensive therapy unit; eGFR estimated glomerular filtration rate; ACE Angiotensin Converting Enzyme; BP blood pressure; ARB Angiotensin Receptor Blocker; NSAID Non-steroidal anti-inflammatory drug.